Angiogenesis as a hallmark of solid tumors - clinical perspectives Jamal MajidpoorKeywan Mortezaee Review 09 April 2021 Pages: 715 - 737
Alteration and dysfunction of ion channels/transporters in a hypoxic microenvironment results in the development and progression of gastric cancer Junling ChenMinglin ZhangXuemei Liu Review Open access 15 April 2021 Pages: 739 - 749
Deciphering molecular mechanisms of metastasis: novel insights into targets and therapeutics Bikashita KalitaMohane Selvaraj Coumar Review 29 April 2021 Pages: 751 - 775
Survivin drives tumor-associated macrophage reprogramming: a novel mechanism with potential impact for obesity E. BenaigesV. Ceperuelo-MallafréS. Fernández-Veledo Original paper Open access 12 March 2021 Pages: 777 - 792
Prognostic role of proliferating CD8+ cytotoxic Tcells in human cancers Niclas C. BlessinWenchao LiStefan Steurer Original Article Open access 17 April 2021 Pages: 793 - 803
Identification of lysosome‐targeting drugs with anti‐inflammatory activity as potential invasion inhibitors of treatment resistant HER2 positive cancers Malene Bredahl HansenMaria PostolTuula Kallunki Original Article Open access 03 May 2021 Pages: 805 - 820
MT1JP-mediated miR-24-3p/BCL2L2 axis promotes Lenvatinib resistance in hepatocellular carcinoma cells by inhibiting apoptosis Ting YuJiajian YuBibo Wang Original Article Open access 11 May 2021 Pages: 821 - 834
Terminal α2,6-sialylation of epidermal growth factor receptor modulates antibody therapy response of colorectal cancer cells Joana G. RodriguesHenrique O. DuarteCelso A. Reis Original Article 13 April 2021 Pages: 835 - 850
Differential regulation of autophagy by STAU1 in alveolar rhabdomyosarcoma and non‐transformed skeletal muscle cells Shekoufeh AlmasiTara E. Crawford ParksBernard J. Jasmin Original Article 26 April 2021 Pages: 851 - 870
CDK7 blockade suppresses super‐enhancer‐associated oncogenes in bladder cancer Yafei YangDonggen JiangJun Pang Original Article 27 April 2021 Pages: 871 - 887
Rabeprazole has efficacy per se and reduces resistance to temozolomide in glioma via EMT inhibition Deepak BabuAnwita MudirajPhanithi Prakash Babu Original Article 04 May 2021 Pages: 889 - 905
The ATO/miRNA-885-5p/MTPN axis induces reversal of drug-resistance in cholangiocarcinoma Yuting WangWen ZhangLin Miao Original Article 25 June 2021 Pages: 907 - 916
A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing Fan FanHao ZhangNan Zhang Original Article 17 June 2021 Pages: 917 - 935
Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer Reiri ShimazakiShigetsugu TakanoMasayuki Ohtsuka Original Article Open access 01 June 2021 Pages: 937 - 950
Functional estrogen receptor signaling pathway activity in high-grade serous ovarian carcinoma as compared to estrogen receptor protein expression by immunohistochemistry Phyllis van der PloegLaura A. M. van LieshoutJurgen M. J. Piek Short Communication Open access 16 March 2021 Pages: 951 - 957
Correction to: Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/β-catenin pathway and upregulating PTEN Guang ShanXike ZhouXuedong Wang Correction Open access 20 July 2021 Pages: 959 - 959